Last reviewed · How we verify
NCT05811663
Health Care Use and Costs of Functional Somatic Disorders
trial in Bodily Distress Syndrome in 9,656 participants. Completed in 30 August 2015.
30 June 2015
Quick facts
| Lead sponsor | Aarhus University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 9,656 |
| Start date | 10 November 2011 |
| Primary completion | 30 June 2015 |
| Estimated completion | 30 August 2015 |
| Sites | 1 location across Denmark |
Conditions studied
- Bodily Distress Syndrome — all drugs for Bodily Distress Syndrome →
- Irritable Bowel — all drugs for Irritable Bowel →
- Fibromyalgia — all drugs for Fibromyalgia →
- Chronic Widespread Pain — all drugs for Chronic Widespread Pain →
Sponsor
Aarhus University Hospital
Who can join
Adults 18 to 76, any sex, with Bodily Distress Syndrome or Irritable Bowel. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational case-control study is to learn about direct healthcare use and costs of functional somatic disorders. The aim of the proposed study is to investigate the use and costs of direct healthcare for individuals with functional somatic disorders. Researchers will compare direct healthcare use and costs of individuals with functional somatic disorders and compare them with that of healthy controls and individuals with other severe physical disease, respectively.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Healthcare use and costs of functional somatic disorder in Denmark: a population-based cohort study (DanFunD).
Petersen MW, Wellnitz KB, Oernboel E, Carstensen TBW, et al · · 2025 · PMID 41431615 · DOI 10.1136/bmjph-2025-003318
Verify or expand the search:
- PubMed search for NCT05811663
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bodily Distress Syndrome
Currently open trials in the same condition.
- NCT04935307 — Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy · NA · active not recruiting
Other Aarhus University Hospital trials
Trials by the same sponsor.
- NCT07432802 — Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer · NA · not yet recruiting
- NCT07499336 — UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST P · not yet recruiting
- NCT07454486 — TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cance · not yet recruiting
- NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
- NCT07426250 — Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05811663 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aarhus University Hospital
- Last refreshed: 13 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811663.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing